Australian farmer launches legal action against Bayer over weedkiller: report

This post was originally published on this site

MELBOURNE (Reuters) – An Australian farmer has launched a legal case against Bayer (DE:) AG’s agricultural chemicals unit Monsanto (NYSE:) after being diagnosed with a type of leukaemia, the Australian Broadcasting Commission reported on Thursday.

New South Wales farmer Ross Wild was diagnosed with Hodgkin’s Lymphoma last year after using the weedkiller Roundup on his farming property near the border of NSW and Victoria since 1976, ABC reported.

He claims that long-term exposure to Roundup’s active ingredient, glyphosate, was to blame, ABC said.

Bayer did not have an immediate comment on the case.

He will be represented by managing partner Tony Carbone of Carbone Lawyers, according to the report. The firm did not did not immediately respond to an email requesting comment.

In June, Carbone Lawyers, acting for an Australian gardener, filed a lawsuit against Bayer for severe harm caused by a Roundup, the first such case in the country.

The lawsuit follows court rulings in the United States linking Roundup’s main ingredient, glyphosate, to cancer, which has already taken tens of billions of euros off Bayer’s market value.

For Bayer – inventor of Aspirin and maker of stroke prevention drug Xarelto and Yasmin birth control pills – lawsuits in the United States are the biggest headache with more than 13,400 plaintiffs bringing claims over the herbicide’s alleged cancer risk.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.